Pot stocks fall as US DEA pushes cannabis reclassification hearing to December

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 51 sec. here
  • 11 min. at publisher
  • 📊 Quality Score:
  • News: 55%
  • Publisher: 63%

U.S. Drug Enforcement Administration News

Medical Cannabis,DEA,Donald Trump

Shares of cannabis companies sank on Tuesday after the U.S. Drug Enforcement Administration (DEA) postponed its cannabis reclassification hearing to Dec. 2, ...

- Shares of cannabis companies sank on Tuesday after the U.S. Drug Enforcement Administration postponed its cannabis reclassification hearing to Dec. 2, after the U.S. presidential election.

The AdvisorShares Pure US Cannabis ETF dipped 9.1%, having fallen as much as 12% earlier in the session. Analysts also noted that the outcome would heavily depend on Trump's choice for key positions such as Attorney General, the director of the DEA, and the Secretary of Health and Human Services, should he win.

Medical cannabis is legal in 38 states and various U.S. territories, while recreational use is permitted in 24 states and Washington, D.C.; however, it remains federally illegal. Violent crimes involving guns – including homicides, shootings and carjackings – have surged in York Region since the start of the year, police said Tuesday, calling the increase troubling for the area north of Toronto.KANSAS CITY, Mo. — Chiefs tight end Travis Kelce and his brother, former Eagles center Jason Kelce, are taking their popular “New Heights” podcast to Amazon's Wondery under a three-year deal that gives the company exclusive advertising sales and distribution rights.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 47. in BUSİNESS

Business Business Latest News, Business Business Headlines